Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human mesor-hypertensive chronorisk.

R C Hermida1, F Halberg, E Haus

  • 1Bioengineering and Chronobiology Laboratories, E.T.S.I.T., University of Vigo, Spain.

Chronobiologia
|September 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Creatinine clearance and blood pressure: a 34-year circadian study.

La Clinica terapeutica·2009
Same author

Why continued surveillance? Intermittent blood pressure and heart rate abnormality under treatment.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2005
Same author

Circadian rhythms of basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), insulin-like growth factor-1 (IGF-1), insulin-like growth factor binding protein-3 (IGFBP-3), cortisol, and melatonin in women with breast cancer.

Chronobiology international·2001
Same author

Circadian rhythms and clinical medicine with applications to hypertension.

American journal of hypertension·2001
Same author

Alterations with aging of the endocrine and neuroendocrine circadian system in humans.

Chronobiology international·2000
Same author

Melatonin levels in women with fibromyalgia and chronic fatigue syndrome.

The Journal of rheumatology·1999
Same journal

Models for chronobiologic risk and prepathology detection. A tribute to Bill W. Kennedy.

Chronobiologia·1994
Same journal

Dora K. (Holly) Hayes.

Chronobiologia·1994
Same journal

Agostino Carandente.

Chronobiologia·1994
Same journal

In defense of proper cosinor analysis.

Chronobiologia·1994
Same journal

"Cancer marker chronomes" assessed in the light of chronobioethics.

Chronobiologia·1994
Same journal

Cardiovascular disease risk monitoring in the light of chronobioethics.

Chronobiologia·1994
See all related articles

Certain hormone levels in blood can predict high blood pressure risk. Circannual and circadian bootstrapping methods identified plasma aldosterone and thyroid stimulating hormone as key endocrine classifiers for cardiovascular risk.

Area of Science:

  • Endocrinology
  • Chronobiology
  • Cardiovascular Health

Background:

  • Endocrine rhythms influence health and disease.
  • Predicting cardiovascular risk is crucial for preventative medicine.

Purpose of the Study:

  • Identify endocrine variables that classify cardiovascular risk.
  • Evaluate the utility of bootstrapping methods for analyzing time-series endocrine data.

Main Methods:

  • Systematic blood sampling of endocrine variables around the clock and seasons.
  • Pattern discrimination, analysis of variance, cosinor analysis, and bootstrapping (circannual and circadian).
  • Analysis of data from adult women, adolescents, and post-menopausal women.

Main Results:

Related Experiment Videos

  • Plasma aldosterone and thyroid stimulating hormone were identified as strong classifiers for high vs. low blood pressure risk.
  • Circannual bootstrapping demonstrated effectiveness in detecting outliers and supporting classifier roles.
  • Bootstrapping results for cortisol, dehydro-epi-androsterone sulfate, and prolactin were tentative, requiring further analysis.

Conclusions:

  • Endocrine classifiers can offer cost-effective checks for cardiovascular risk.
  • Circadian and circannual bootstrapping represent a significant potential for health maintenance chrono-engineering.
  • Future applications may focus on newborns, considering potential genetic origins of endocrine risk factors.